Comparative Effectiveness of First-Line Biologic Therapies in Ulcerative Colitis (FIRST-UC) - Studio Regionale Leggi tutto A Multicenter, Prospective Real-life Evaluation of Effectiveness and Safety of Etrasimod in Biologic-Experienced Patients with Moderate-to-Severe Ulcerative Colitis Over One Year Leggi tutto The REAL-SEQUENCE Study: a real-life comparative effectiveness of ustekinumab and risankizumab in patients with Crohn’s disease after anti-TNFα failure or intolerance – an IG-IBD Study Leggi tutto Multicenter Analysis of Pouchitis Classification, Diagnosis, and Treatment Outcomes in Italian Patients with Ileal Pouch-Anal Anastomosis for Inflammatory Bowel Disease: an IG- IBD Initiative | POUCH-CARE Leggi tutto Upadacitinib: Personalized Goals for Remission and Disease Evaluation in Patients with Crohn’s Disease (UPGRADE-CD) Leggi tutto Effectiveness and safety of switching from a first JAKi to subsquent JAKi in patients with ulcerative colitis: a real-life multicentre cohort study - JAKi Leggi tutto Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in patients with Ulcerative Colitis - MIRACLE-UC Leggi tutto RESOLVE: Risankizumab Evaluation Study of Outcomes in real Life and Verification of Effectiveness and safety Leggi tutto Switching from UStekinumab originator to BIOSimilar in Crohn’s disease: The USBIOS Study, an IG-IBD study Leggi tutto Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
A Multicenter, Prospective Real-life Evaluation of Effectiveness and Safety of Etrasimod in Biologic-Experienced Patients with Moderate-to-Severe Ulcerative Colitis Over One Year Leggi tutto The REAL-SEQUENCE Study: a real-life comparative effectiveness of ustekinumab and risankizumab in patients with Crohn’s disease after anti-TNFα failure or intolerance – an IG-IBD Study Leggi tutto Multicenter Analysis of Pouchitis Classification, Diagnosis, and Treatment Outcomes in Italian Patients with Ileal Pouch-Anal Anastomosis for Inflammatory Bowel Disease: an IG- IBD Initiative | POUCH-CARE Leggi tutto Upadacitinib: Personalized Goals for Remission and Disease Evaluation in Patients with Crohn’s Disease (UPGRADE-CD) Leggi tutto Effectiveness and safety of switching from a first JAKi to subsquent JAKi in patients with ulcerative colitis: a real-life multicentre cohort study - JAKi Leggi tutto Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in patients with Ulcerative Colitis - MIRACLE-UC Leggi tutto RESOLVE: Risankizumab Evaluation Study of Outcomes in real Life and Verification of Effectiveness and safety Leggi tutto Switching from UStekinumab originator to BIOSimilar in Crohn’s disease: The USBIOS Study, an IG-IBD study Leggi tutto Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
The REAL-SEQUENCE Study: a real-life comparative effectiveness of ustekinumab and risankizumab in patients with Crohn’s disease after anti-TNFα failure or intolerance – an IG-IBD Study Leggi tutto Multicenter Analysis of Pouchitis Classification, Diagnosis, and Treatment Outcomes in Italian Patients with Ileal Pouch-Anal Anastomosis for Inflammatory Bowel Disease: an IG- IBD Initiative | POUCH-CARE Leggi tutto Upadacitinib: Personalized Goals for Remission and Disease Evaluation in Patients with Crohn’s Disease (UPGRADE-CD) Leggi tutto Effectiveness and safety of switching from a first JAKi to subsquent JAKi in patients with ulcerative colitis: a real-life multicentre cohort study - JAKi Leggi tutto Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in patients with Ulcerative Colitis - MIRACLE-UC Leggi tutto RESOLVE: Risankizumab Evaluation Study of Outcomes in real Life and Verification of Effectiveness and safety Leggi tutto Switching from UStekinumab originator to BIOSimilar in Crohn’s disease: The USBIOS Study, an IG-IBD study Leggi tutto Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Multicenter Analysis of Pouchitis Classification, Diagnosis, and Treatment Outcomes in Italian Patients with Ileal Pouch-Anal Anastomosis for Inflammatory Bowel Disease: an IG- IBD Initiative | POUCH-CARE Leggi tutto Upadacitinib: Personalized Goals for Remission and Disease Evaluation in Patients with Crohn’s Disease (UPGRADE-CD) Leggi tutto Effectiveness and safety of switching from a first JAKi to subsquent JAKi in patients with ulcerative colitis: a real-life multicentre cohort study - JAKi Leggi tutto Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in patients with Ulcerative Colitis - MIRACLE-UC Leggi tutto RESOLVE: Risankizumab Evaluation Study of Outcomes in real Life and Verification of Effectiveness and safety Leggi tutto Switching from UStekinumab originator to BIOSimilar in Crohn’s disease: The USBIOS Study, an IG-IBD study Leggi tutto Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Upadacitinib: Personalized Goals for Remission and Disease Evaluation in Patients with Crohn’s Disease (UPGRADE-CD) Leggi tutto Effectiveness and safety of switching from a first JAKi to subsquent JAKi in patients with ulcerative colitis: a real-life multicentre cohort study - JAKi Leggi tutto Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in patients with Ulcerative Colitis - MIRACLE-UC Leggi tutto RESOLVE: Risankizumab Evaluation Study of Outcomes in real Life and Verification of Effectiveness and safety Leggi tutto Switching from UStekinumab originator to BIOSimilar in Crohn’s disease: The USBIOS Study, an IG-IBD study Leggi tutto Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Effectiveness and safety of switching from a first JAKi to subsquent JAKi in patients with ulcerative colitis: a real-life multicentre cohort study - JAKi Leggi tutto Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in patients with Ulcerative Colitis - MIRACLE-UC Leggi tutto RESOLVE: Risankizumab Evaluation Study of Outcomes in real Life and Verification of Effectiveness and safety Leggi tutto Switching from UStekinumab originator to BIOSimilar in Crohn’s disease: The USBIOS Study, an IG-IBD study Leggi tutto Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in patients with Ulcerative Colitis - MIRACLE-UC Leggi tutto RESOLVE: Risankizumab Evaluation Study of Outcomes in real Life and Verification of Effectiveness and safety Leggi tutto Switching from UStekinumab originator to BIOSimilar in Crohn’s disease: The USBIOS Study, an IG-IBD study Leggi tutto Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
RESOLVE: Risankizumab Evaluation Study of Outcomes in real Life and Verification of Effectiveness and safety Leggi tutto Switching from UStekinumab originator to BIOSimilar in Crohn’s disease: The USBIOS Study, an IG-IBD study Leggi tutto Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Switching from UStekinumab originator to BIOSimilar in Crohn’s disease: The USBIOS Study, an IG-IBD study Leggi tutto Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Risk of relapse and retreatment success after vedolizumab discontinuation in IBD patients in long-standing remission Leggi tutto Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Impact of access to heaLthcare on diAgnosTic dElay in iNflammatory bowEl diSeaSe (LATENESS) - Studio Regionale (Lazio) Leggi tutto Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Effectiveness and safety of upadacitinib in patients with ulcerative colitis: a real-life, multicenter, IG-IBD study (UPAREAL_UC) Leggi tutto LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
LA FERTILITÀ NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI NELL’ERA DEI FARMACI BIOLOGICI E DELLA CHIRURGIA MINI-INVASIVA Leggi tutto ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
ADENOCARCINOMA DEL COLON-RETTO MUCINOSO E ANELLO CON CASTONE NEI PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI: STUDIO MULTICENTRICO (IBD_CRC) Leggi tutto Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Real-life effectiveness and safety of tofacitinib and vedolizumab as a secondline therapy in anti-TNFs experienced patients with moderately to severely active ulcerative colitis (VE2TO_UC) Leggi tutto Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Comparative efficacy of switch strategy and swap strategy in CD patients after failure of first-line therapy with anti-TNF: a retrospective, observational, multicenter study. (SWIvSWAP) Leggi tutto HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
HEmorrhoidAl Disease in Inflammatory Bowel Disease (HEAD-IBD) Leggi tutto Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Pediatric versus Adult Ulcerative Colitis natural History: a prospective, observational multicenter study (PAUCH) Leggi tutto Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Comparison of two strategies for the prevention of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study (POR) Leggi tutto Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
Switching from VEDOlizumab intravenous to subcutaneous formulation in patients with ulcerative colitis in clinical remission: an observational study (SVEDO study) Leggi tutto
